MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, AVTX has $99,885K in assets. $31,565K in debts. $24,988K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
765.80%
Quick Ratio
765.80%
Cash Ratio
215.43%
Debt to Asset Ratio
31.60%
Unit: Thousand (K) dollars
Assets Breakdown
    • Short-term investments
    • Cash and cash equivalents
    • Goodwill
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Derivative liability, non-curren...
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
24,988 15,858 26,963 42,290
Short-term investments
57,005 82,478 84,654 70,972
Prepaid expenses and other current assets
6,685 6,913 2,139 1,903
Restricted cash, current portion
147 37 90 20
Total current assets
88,825 105,286 113,846 115,185
Property and equipment, net
375 460 542 686
Goodwill
10,502 10,502 10,502 10,502
Restricted cash, net of current portion
183 210 210 210
Total assets
99,885 116,458 125,100 126,583
Derivative liability, current
-0 0 370
Accounts payable
356 137 474 2,366
Accrued expenses and other current liabilities
11,243 12,803 7,498 6,523
Total current liabilities
11,599 12,940 7,972 9,259
Royalty obligation
2,000 2,000 2,000 2,000
Deferred tax liability, net
446 434 304 293
Derivative liability, non-current
17,520 18,000 23,160 10,260
Other long-term liabilities
0 35 117 197
Total liabilities
31,565 33,409 33,553 22,009
Temporary equity, values issued-Series DPreferred Stock
0 0 0 0
Temporary equity, values issued-Series EPreferred Stock
0 0 0 0
Common stock0.001 par value 200,000,000 shares authorized at march31, 2026 and december31, 2025 24,637,807 and 18,512,757 shares issued and outstanding at march31, 2026 and december31, 2025, respectively
25 18 18 11
Additional paid-in capital
536,453 531,485 526,290 508,774
Accumulated other comprehensive (loss) income
-6 68 41 -34
Accumulated deficit
-468,152 -448,522 -434,802 -404,177
Temporary equity, values issued
---0
Total stockholders equity
68,320 83,049 91,547 104,574
Total liabilities, mezzanine equity and stockholders equity
99,885 116,458 125,100 126,583
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short-term investments$57,005K Cash and cashequivalents$24,988K Prepaid expenses andother current assets$6,685K Restricted cash, currentportion$147K Total current assets$88,825K Goodwill$10,502K Property and equipment,net$375K Restricted cash, net ofcurrent portion$183K Total assets$99,885K Total liabilities,mezzanine equity and...$99,885K Total stockholdersequity$68,320K Total liabilities$31,565K Accumulated deficit-$468,152K Accumulated othercomprehensive (loss) income-$6K Additional paid-in capital$536,453K Derivative liability,non-current$17,520K Total currentliabilities$11,599K Royalty obligation$2,000K Deferred tax liability,net$446K Common stock0.001 parvalue 200,000,000...$25K Accrued expenses andother current...$11,243K Accounts payable$356K

Avalo Therapeutics, Inc. (AVTX)

Avalo Therapeutics, Inc. (AVTX)